Literature DB >> 16370163

Vasculitis and infection: effects of immunosuppressive therapy.

H M Lode1, M Schmidt-Ioanas.   

Abstract

The immunosuppressive therapy in systemic vasculitis leads to immunological dysfunctions. The consequences of granulocytopenia and cellular immune deficits are infections of different etiologies in up to 50% of vasculitis patients. The leading severe infections are sepsis and pneumonia induced by a broad spectrum of pathogens (extra- and intra-cellular growing bacteria, fungi, parasites and viruses). The contribution of infections to the mortality of vasculitis patients is important and should induce early and careful control of these events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16370163     DOI: 10.5414/cnp64475

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Clinical outcomes of ANCA-associated vasculitis in elderly patients.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; István Mucsi
Journal:  Int Urol Nephrol       Date:  2014-04-23       Impact factor: 2.370

2.  Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample.

Authors:  Mavi Rivera; A Villafranca; P Khamooshi; V Reyes; J Sanchez; A Manadan
Journal:  Clin Rheumatol       Date:  2021-08-28       Impact factor: 2.980

Review 3.  Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.

Authors:  Nathan M Markarian; Gaël Galli; Dhanesh Patel; Mark Hemmings; Priya Nagpal; Albert M Berghuis; Levon Abrahamyan; Silvia M Vidal
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.